Eliminating the need for daily injections: Crystec and Biosidus aim to disrupt delivery of biotherapeutics 27-Oct-2021 By Jane Byrne Crystec Ltd and Biosidus SA are teaming up to focus on enhancing the delivery and performance of biotherapeutics.